Figure 1.
Primary outcomes used in PMR and GCA RCTs and time points of their assessment. AEs: adverse events; BMC: bone mineral content; BMD: bone mineral density; GC: glucocorticoids; N: number; PMR-AS: PMR activity score; pts: patients; T: time; W: week; Δ, change in. * Clinical efficacy was defined as (reduction of limb gridle pain, morning stiffness, ESR, CRP, fibrinogen, steroid dosage) at W2, 4, 6 and 12. Each reference is inserted as an exponential number

Primary outcomes used in PMR and GCA RCTs and time points of their assessment. AEs: adverse events; BMC: bone mineral content; BMD: bone mineral density; GC: glucocorticoids; N: number; PMR-AS: PMR activity score; pts: patients; T: time; W: week; Δ, change in. * Clinical efficacy was defined as (reduction of limb gridle pain, morning stiffness, ESR, CRP, fibrinogen, steroid dosage) at W2, 4, 6 and 12. Each reference is inserted as an exponential number

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close